Concourse Financial Group Securities, Inc. Revolution Medicines, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.52 Billion
Q1 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$26.56 - $33.55 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$18.35 - $34.12 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$25.17 - $35.05 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$25.17 - $35.05 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$20.28 - $27.0 $0 - $0	0 New	0 $0

Q1 2023 May 15, 2023	BUY	$20.76 - $30.09 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$17.68 - $25.53 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$17.46 - $26.0 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$14.54 - $27.17 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$17.31 - $26.4 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$24.35 - $33.7 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	BUY	$23.95 - $33.41 $0 - $0	0 New	0 $0
Q2 2021 Aug 13, 2021	BUY	$29.0 - $47.44 $0 - $0	0 New	0 $0
Q1 2021 May 13, 2021	BUY	$37.21 - $54.43 $0 - $0	0 New	0 $0
Q4 2020 Feb 02, 2021	BUY	$30.19 - $45.49 $0 - $0	0 New	0 $0
Q3 2020 Nov 13, 2020	BUY	$22.61 - $34.8 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$19.65 - $39.34 $0 - $0	0 New	0 $0
Q1 2020 May 13, 2020	BUY	$20.0 - $34.08 $0 - $0	0 New	0 $0

Others Institutions Holding RVMD

# of Institutions

219

Shares Held

153M

Call Options Held

321K

Put Options Held

111K

Vanguard Group Inc Valley Forge, PA

14.8M
Shares

$584 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

14.7M
Shares

$582 Million
0.09% of portfolio
Black Rock Inc. New York, NY

12.3M
Shares

$487 Million
0.01% of portfolio
Baker Bros. Advisors LP New York, NY

7.55M
Shares

$299 Million
3.08% of portfolio
Farallon Capital Management LLC San Francisco, CA

7.51M
Shares

$297 Million
1.13% of portfolio

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.47B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account